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General Procedures 
Dry solvents were freshly distilled under argon from an appropriate drying agent before use. Dry 
THF was obtained using Solvent Purification System (SPS). Toluene and CH2Cl2 was 
purchased from Aldrich. Gold complex Au1 was purchased from Aldrich. All other chemicals 
were purchased from Aldrich, TCI or Alfa Aesar and used without further purification, unless 
otherwise noted. Reactions were conducted in dry solvents under argon atmosphere unless 
otherwise stated. The abbreviation “rt” refers to reactions carried out approximately at 23ºC. 
Reaction mixtures were stirred using Teflon-coated magnetic stirring bars. Reaction 
temperatures were maintained using Thermowatch-controlled silicone oil baths. Thin-layer 
chromatography (TLC) was performed on silica gel plates and components were visualized by 
observation under UV light, and / or by treating the plates with p-anisaldehyde or cerium nitrate 
solutions, followed by heating. Flash chromatography was carried out on silica gel unless 
otherwise stated. Dryings were performed with anhydrous Na2SO4 or MgSO4. Concentration 
refers to the removal of volatile solvents via distillation using a Büchi rotary evaporator followed 
by residual solvent removal under high vacuum. NMR spectra were recorded in CDCl3, at 250 
MHz (Bruker), 300 MHz (Varian), 400 MHz (Varian) or 500 MHz (Varian) for cycloadducts. 
Carbon types and structure assignments were determined from DEPT-NMR and two-
dimensional experiments (HMQC and HMBC, COSY and NOESY). NMR spectra were analyzed 
using MestreNova© NMR data processing software (www.mestrelab.com). The following 
abbreviations are used to indicate signal multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; 
dd, double doublet; td, triple doublet; m, multiplet; br, broad. Mass spectra were acquired using 
chemical ionization (CI) electron impact (EI), or electrospray ionization (ESI) and were recorded 
at the CACTUS facility of the University of Santiago de Compostela. The reactions were 
monitored by TLC or GC-MS using the Agilent Technologies 6890N, Network GC System, 
equipped with the Agilent 190915-433 column and the Agilent 5973 Inert Mass Selective 
Detector in Electron Impact or Chemical Ionization Mode (with Methane).  
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Experimental data 
Experimental procedures for the synthesis of -Unsaturated Hydrazones (2). 
Exemplified for the synthesis of 2a 
 
MgSO4 (0.99 mg, 8.21 mmol) and N,N-diisorpropylhidrazine (20.5 mmol, 2.4 g) were added to a 
solution of (E)-2-methyl-3-phenylacrylaldehyde (0.96 ml, 6.84 mmol) in CH2Cl2 (3.4 ml). After 
stirring at rt for 24h, the mixture was filtered, washed with brine (5 ml) and extracted (CH2Cl2, 2 
x 10 ml). The combined organic phases were dried, filtered and evaporated to yield a crude oil 
that was purified by column chromatography (hexanes: EtOAc 8:2) to afford the hydrazone 2a 
(1.48 g) in 89% yield. Yellow solid. (1E,2E)-2-Methyl-3-phenylacrylaldehyde 
diisopropylhydrazone. 1H NMR (300 MHz, CDCl3) δ 7.61 – 7.41 (m, 4H), 7.40 – 7.22 (m, 2H), 
6.59 (s, 1H), 4.06 – 3.96 (m,2H), 2.37 (d, J = 1.2 Hz, 3H), 1.36 (d, J = 6.5 Hz, 12H). 13C NMR 
(75 MHz, CDCl3) δ 138.60 (C), 138.01 (C), 132.34 (CH), 128.96 (CH), 128.12 (CH), 127.44 
(CH), 125.83 (CH), 47.47 (CH), 20.97 (CH3), 13.59 (CH3). LRMS (ESI): 245 (M
+ +1), 203, 161, 
144, 118, 86; HRMS calculated for C16H25N2 245.2012, found 245.2010. 
(1E,2E)-3-Phenylacrylaldehyde diisopropylhydrazone (2b) 
Yellow oil, 83% yield. 1H NMR (300 MHz, CDCl3) δ 7.45 (d, J = 8.7 Hz, 2H), 
7.32 (t, J = 7.6 Hz, 2H), 7.27 – 7.15 (m, 2H), 7.04 (dd, J = 15.9, 8.7 Hz, 1H), 
6.50 (d, J = 15.9 Hz, 1H), 3.88 (hept, J = 6.6 Hz, 2H), 1.22 (d, J = 6.6 Hz 
12H). 13C NMR (75 MHz, CDCl3) δ 138.05 (C), 129.43 (CH), 129.40 (CH), 128.43 (CH), 127.82 
(CH), 126.46 (CH), 125.78 (CH), 47.49 (CH), 20.81 (CH3). LRMS (ESI): 231 (M
+ +1), 203. 189, 
173, 147, 132, 100, 86; HRMS calculated for C15H23N2 231.1856, found 231.1855. 
(1E,2E)-3-(4-Methoxyphenyl)acrylaldehyde diisopropylhydrazone (2c) 
Yellow solid, 87% yield. 1H NMR (300 MHz, CDCl3) δ 7.35 (d, J = 
8.8 Hz, 2H), 7.20 (d, J = 8.7 Hz, 1H), 6.93 – 6.82 (m, 3H), 6.44 (d, J 
= 15.9 Hz, 1H), 3.89 – 3.81 (m, 2H), 3.81 (s, 3H), 1.19 (d, J = 6.6 
Hz, 12H). 13C NMR (75 MHz, CDCl3) δ 158.71 (C), 131.07 (C), 130.48 (CH), 128.02 (CH), 
127.62 (CH), 127.16 (CH), 114.15 (CH), 55.38 (CH3), 47.64 (CH), 20.99 (CH3). LRMS (ESI): 
261 (M+ + 1), 235, 219, 203, 177, 162, 135, 86; HRMS calculated for C16H25N2O 261.1961, 
found 261.1957. 
(1E,2E)-3-(4-Fluorophenyl)acrylaldehyde diisopropylhydrazone (2d) 
White solid, 93% yield 1H NMR (300 MHz, CDCl3) δ 7.36 (dd, J = 8.4, 
5.7 Hz, 2H), 7.17 (d, J = 8.7 Hz, 1H), 7.02 – 6.83 (m, 3H), 6.42 (d, J = 
15.9 Hz, 1H), 3.85 (hept, J = 6.5 Hz, 2H), 1.19 (d, J = 6.5 Hz, 12H). 
13C NMR (75 MHz, CDCl3) δ 161.84 (d, J = 245.9 Hz, C), 134.47 (d, J = 3.0 Hz, C), 129.44 (d, J 
= 2.0 Hz, CH), 129.34 (CH), 127.32 (d, J = 7.7 Hz, CH), 126.71 (CH), 115.55 (d, J = 21.5 Hz, 
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CH), 47.73 (CH), 21.01 (CH3). LRMS (ESI): 249 (M
+ + 1), 165, 150, 123, 100, 86; HRMS 
calculated for C15H22N2F 249.1762, found 249.1761. 
(1E,2E)-2,3-Diphenylacrylaldehyde diisopropylhydrazone (2e).1 
Yellow oil, 43% yield. 1H NMR (300 MHz, CDCl3) δ 7.36 – 7.20 (m, 7H), 
7.12 – 7.01 (m, 2H), 6.99 – 6.93 (m, 2H), 6.55 (s, 1H), 3.81 (hept, J = 6.5 
Hz, 2H), 1.06 (d, J = 6.5 Hz, 12H). LRMS (ESI): 307 (M+ + 1), 282, 265, 
206, 179, 163, 86; HRMS calculated for C21H27N2 307.2169, found 307.2178. 
(1E,2E)-2-Methylbut-2-enal diisopropylhydrazone (2f) 
Yellow oil, 72% yield. 1H NMR  (300 MHz, CDCl3) δ 7.04 (s, 1H), 5.45 (q, J = 
6.7 Hz, 1H), 3.73 (hept, J = 6.5 Hz, 2H), 1.84 (s, 3H), 1.74 (d, J = 7.0 Hz, 
3H), 1.11 (d, J = 6.6 Hz, 12H). 13C NMR (75 MHz, CDCl3) δ 136.56 (C), 
134.39 (CH), 123.53 (CH), 47.14 (CH), 20.74 (CH3), 13.65 (CH3), 11.48 (CH3). LRMS (ESI): 183 
(M+ + 1), 141, 125, 86; HRMS calculated for C11H23N2 183.1856, found 183.1853. 
(1E,2E)-2-Phenylbut-2-enal diisopropylhydrazone (2g) 
 Yellow oil, 37% yield.1H NMR (300 MHz, CDCl3) δ 7.47 – 7.20 (m, 6H), 
5.82 (q, J = 7.2 Hz, 1H), 3.85 – 3.71 (m, 2H), 1.76 (d, J = 7.1 Hz, 3H), 1.08 
(d, J = 6.5 Hz, 12H). 13C NMR (126 MHz, CDCl3) δ 130.45 (C), 130.41 
(CH), 130.21 (CH), 128.30 (CH), 127.27 (CH), 126.26 (C), 125.93 (CH), 52.25 (CH), 20.86 
(CH3), 19.48 (CH3). LRMS (ESI): 245 (M
+ + 1), 203, 177, 161, 144, 118, 100, 86; HRMS 
calculated for C16H25N2  245.2012, found 245.2010. 
(1E,2E)-But-2-enal diisopropylhydrazone (2h) 
Yellow oil, 77% yield. 1H NMR (300 MHz, CDCl3) δ 7.04 (d, J = 8.7 Hz, 1H), 
6.30 – 6.18 (m, 1H), 5.71 – 5.56 (m, 1H), 3.80 – 3.66 (m, 2H), 1.79 (dd, J = 
6.8, 1.4 Hz, 3H), 1.12 (d, J = 6.6 Hz, 12H). 13C NMR (75 MHz, CDCl3) δ 
131.90 (CH), 131.62 (CH), 126.25 (CH), 47.33 (CH), 20.83 (CH3), 18.19 (CH3). LRMS (ESI): 
169 (M+ + 1), 127, 111, 100, 86; HRMS calculated for C10H21N2  169.1699, found 169.1697. 
Cyclohex-1-ene-1-carbaldehyde diisopropylhydrazone (2i) 
Yellow oil, 83% yield. 1H NMR (300 MHz, CDCl3) δ 7.03 (s, 1H), 5.71 – 5.64 
(m, 1H), 3.75 (hept, J = 6.5 Hz, 2H), 2.37 – 2.30 (m, 2H), 2.20 – 2.10 (m, 
2H), 1.70 – 1.60 (m, 4H), 1.13 (d, J = 6.6 Hz, 12H). 13C NMR (75 MHz, 
CDCl3) δ 137.80 (C), 132.76 (CH), 126.13 (CH), 47.09 (CH), 25.85 (CH2), 24.22 (CH2), 23.17 
(CH2), 22.67 (CH2), 20.80 (CH3). LRMS (ESI): 209 (M
+ + 1), 167, 141, 125, 86. HRMS 
calculated for C13H25N2  209.2012, found 209.2007. 
Cyclopent-1-ene-1-carbaldehyde diisopropylhydrazone (2j)  
Yellow oil, 69% yield. 1H NMR (300 MHz, CDCl3) δ 7.26 (s, 1H), 5.65 – 5.59 
(m, 1H), 3.79 (hept, J = 6.5 Hz, 2H), 2.61 (td, J = 7.7, 1.9 Hz, 2H), 2.51 – 
2.39 (m, 2H), 1.95 – 1.84 (m, 2H), 1.15 (d, J = 6.5 Hz, 12H). 13C NMR (126 
                                                            
1 This product turned out to be unstable. It was immediately used after purification. 
N-N(iPr)2
2i
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MHz, CDCl3) δ 137.78 (C), 126.26, (CH), 125.80, (CH), 47.62 (CH), 32.85 (CH2), 31.28 (CH2), 
22.98 (CH2), 20.72 (CH3). LRMS (ESI): 217 (M
+ + Na), 209, 172, 115, 86; HRMS calculated for 
C12H22N2Na  217.1675 found 217.1682. 
Ethyl (2E, 4E)-4-(2,2-diisopropylhydrazono)-3-methylbut-2-enoate (2k) 
Yellow oil, 74% yield. 1H NMR (300 MHz, CDCl3) δ 6.95 (s, 1H), 5.65 (s, 
1H), 4.16 (q, J = 7.1 Hz, 2H), 3.93 – 3.80 (m, 2H), 2.39 (d, J = 1.1 Hz, 
3H), 1.28 (t, J = 7.1 Hz, 3H), 1.19 (d, J = 6.5 Hz, 12H). 13C NMR (75 MHz, 
CDCl3) δ 168.02 (C), 155.32 (C), 128.13 (CH), 113.88 (CH), 59.39 (CH), 
48.34 (CH2), 21.09 (CH3), 14.60 (CH3), 13.56 (CH3). LRMS (ESI): 241 (M
+ + 1), 199, 153, 112, 
100; HRMS calculated for C13H25N2O2 241.1911, found 241.1910. 
(1E,2E)-2-Methyl-3-phenylacrylaldehyde dimethyldrazone (2a’) 
White solid, 74% yield. 1H NMR (500 MHz, CDCl3) δ 7.43 – 7.36 (m, 4H), 
7.29 – 7.24 (m, 1H), 7.19 (s, 1H), 6.58 (s, 1H), 2.95 (s, 6H), 2.20 (s, J = 1.3 
Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 139.17 (CH), 137.94 (C), 136.41 (C), 
130.66 (CH), 129.14 (CH), 128.24 (CH), 126.49 (CH), 43.09 (CH3), 13.50 (CH3). LRMS (ESI): 
189 (M+ + 1), 173, 146, 117, 91; HRMS calculated for C12H17N2 189.1386, found 189.1381. 
(1E,2E)-3-Phenylacrylaldehyde dimethylhydrazone (2b’) 
Yellow solid, 99% yield. 1H NMR (500 MHz, CDCl3) δ 7.45 (d, J = 8.0 Hz, 2H), 
7.35 (t, J = 7.7 Hz, 2H), 7.24 (t, J = 7.3 Hz, 1H), 7.16 (d, J = 9.0 Hz, 1H), 7.04 – 
6.97 (m, 1H), 6.64 (d, J = 15.9 Hz, 1H), 2.94 (s, 6H). 13C NMR (126 MHz, 
CDCl3) δ 137.31 (C), 135.07 (CH), 131.57 (CH), 128.62 (CH), 127.56 (CH), 127.33 (CH), 
126.18 (CH), 42.70 (CH3). LRMS (ESI): 175 (M
+ + 1), 148, 132, 115; HRMS calculated for 
C11H15N2 175.1230, found 175.1228. 
(1E,2E)-3-(4-Methoxyphenyl)acrylaldehyde dimethylhydrazone (2c’) 
Yellow solid, 93% yield. 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.33  δ 
7.34 (d, J = 8.9 Hz, 2H), 7.14 (d, J = 8.9 Hz, 1H), 6.85 (d, J = 8.8 Hz, 
2H), 6.81 (dd, J = 16.0, 8.9 Hz, 1H), 6.57 (d, J = 15.9 Hz, 1H), 3.79 
(s, 3H), 2.89 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 159.24 (C), 136.22 (CH), 131.76 (CH), 
130.16 (C), 127.54 (CH), 125.57 (CH), 114.20 (CH), 55.35 (CH3), 42.94 (CH3). LRMS (ESI): 205 
(M+ + 1), 178, 160, 133,117, 90; HRMS calculated for C12H17N2O 205.1335, found 205.1335. 
(1E,2E)-2-Methylbut-2-enal dimethylhydrazone (2f’) 
Yellow oil, 72% yield. 1H NMR (300 MHz, CDCl3) δ 6.95 (s, 1H), 5.54 (q, J = 
6.7 Hz, 1H), 2.72 (s, 6H), 1.77 – 1.75 (m, 3H), 1.70 (dd, J = 7.0, 0.9 Hz, 3H). 
13C NMR (75 MHz, CDCl3) δ 140.24 (CH), 135.24 (C), 126.99 (CH), 43.06 
(CH3), 13.67 (CH3), 11.27 (CH3). LRMS (ESI): 127 (M
+ + 1), 111, 84; HRMS calculated for 
C7H15N2 127.1230, found 127.1235. 
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Ethyl (2E,4Z)-4-(2,2-dimethylhydrazono)-3-methylbut-2-enoate (2k’) 
Yellow oil, 74% yield. 1H NMR (500 MHz, CDCl3) δ 6.74 (d, J = 6.1 Hz, 
1H), 5.66 (d, J = 5.8 Hz, 1H), 4.13 – 4.04 (m, 2H), 2.94 – 2.88 (m, 6H), 
2.29 – 2.24 (m, 3H), 1.23 – 1.17 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 
167.29 (C), 153.16 (C), 132.66 (CH), 116.25 (CH), 59.32 (CH2), 42.30 (CH3), 14.31 (CH3), 13.19 
(CH3). LRMS (ESI): 185 (M
+ + 1), 139, 111, 96; HRMS calculated for C9H16N2O2185.1285, 
found 185.1286. 
(2S)-2-(Methoxymethyl)-N-[(1E,2E)-2-methyl-3-phenylprop-2-en-1-ylidene]pyrrolidin-1-amine 
(2a’’) 
Yellow oil, 67 % yield. 1H NMR (300 MHz, CDCl3) δ 7.39 – 7.35 (m, 4H), 
7.26 – 7.18 (m, 1H), 7.15 (s, 1H), 6.50 (s, 1H), 3.70 – 3.58 (m, 2H), 3.54 – 
3.45 (m, 2H), 3.42 (s, 3H), 3.01 (dd, J = 16.8, 7.9 Hz, 1H), 2.16 (d, J = 1.2 
Hz, 3H), 2.12 – 1.84 (m, 4H). 13C NMR (75 MHz, CDCl3) δ 138.61 (CH), 
138.11 (C), 136.74 (C), 129.64 (CH), 129.05 (CH), 128.18 (CH), 126.27 (CH), 74.62 (CH2), 
63.19 (CH3), 59.27 (CH), 49.12 (CH2), 26.87 (CH2), 22.28 (CH2), 13.45 (CH3). LRMS (ESI): 259 
(M+ + 1), 227, 146, 114, 91; HRMS calculated for C16H23N2O 259.1805, found 259.1803. 
(2S)-2-(Methoxymethyl)-N-[(1E,2E)-2-methylbut-2-en-1-ylidene]pyrrolidin-1-amine (2f’’) 
Yellow oil, 65 % yield. 1H NMR  (300 MHz, CDCl3) δ 7.02 (s, 1H), 5.57 (q, 
J = 6.9 Hz, 1H), 3.65 – 3.59 (m, 1H), 3.49 – 3.42 (m, 2H), 3.40 – 3.37 (m, 
4H), 2.90 – 2.79 (m, 1H), 2.00 – 1.84 (m, 4H), 1.83 – 1.81 (m, 3H), 1.76 
(dd, J = 7.0, 0.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 140.25 (CH), 
135.70 (C), 126.33 (CH), 74.85 (CH2), 63.44 (CH), 59.37 (CH3), 49.65 (CH2), 26.90 (CH2), 22.27 
(CH2), 13.90 (CH3), 11.46 (CH3).  
Synthesis of (1E,2Z)-3-phenylacrylaldehyde diisopropylhydrazone (Z-2b) 
 
Dess-Martin periodinane (1.04 g, 2.46 mmol) was added to a solution of (Z)-3-fenilprop-2-en-1-
ol2 (300 mg, 2.24 mmol) in CH2Cl2 (2.5 ml)  and the resulting mixture was stirred for 4h at rt. 
Then, solutions of NaHCO3 (1 ml) and H2S2O3 (1 ml) were subsequently added and the resulting 
mixture was stirred for 15 min. After extraction with CH2Cl2 (2 x 5 ml), the combined organic 
phases were washed with NaClsat (10 ml), dried and concentrated to provide a crude residue 
containing the (Z)-3-phenylacrylaldehyde,3 which was subsequently treated with diisopropyl 
hydrazine and MgSO4 (16h at rt) to provide the hydrazone Z-2b, which was obtained in 81% 
yield after column chromatography. (1E,2E)-3-Phenylacrylaldehyde diisopropylhydrazone (Z-
2b). 1H NMR  (300 MHz, CDCl3)  δ 7.55 (d, J = 9.0 Hz, 1H), 7.40 – 7.30 (m, 4H), 7.27 – 7.17 (m, 
1H), 6.48 – 6.31 (m, 2H), 3.82 (hept, J = 6.6 Hz, 2H), 1.19 (d, J = 6.6 Hz, 12H). 13C NMR (75 
                                                            
2 Pavlakos E., Georgiou T., Tofi M., Montagnon T.,Vassilikogiannakis G. Org. Lett.2009, 11, 4556-4559. 
3 Fehr C., Magpantay I., Vuagnoux M., Dupau P. Chem. Eur. J. 2011, 17, 1257-1260 
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MHz, CDCl3) δ 138.64 (C), 130.57 (CH), 128.77 (CH), 128.35 (CH), 126.33 (CH), 126.18 (CH), 
124.96 (CH), 47.87 (CH), 21.02 (CH3). LRMS (ESI): 231 (M
+ + 1), 189, 132, 86. HRMS 
calculated for C15H23N2 231.1856, found 231.1847. 
Experimental procedure for the Au1-catalyzed [2+2] cycloaddition. Exemplified for the 
cycloaddition of 1a and 2a 
 
The gold complex Au1 (12.3 mg, 0.016 mmol) was added to a solution of 1a (40 mg, 0.32 
mmol) and 2a (156 mg, 0.64 mmol) in (CH2)2Cl2 (1.3 ml) at rt. The resulting mixture was stirred 
for 10 min, filtered through florisil (eluting with CH2Cl2) and concentrated. The crude residue 
was purified on column chromatography (hexanes: EtOAc 7:3) to afford 117 mg of the [2+2] 
cycloadduct 3aa (0.32 mmol, 99% yield). (1R,2Z,4R)-1-methyl-2-[(2-oxo-1,3-oxazolidin-3-
yl)methylene]-4-phenylcyclobutanecarbaldehyde diisopropylhydrazone (3aa). Yellow solid. 1H 
NMR (500 MHz, CDCl3) δ 7.32 (t, J = 7.6 Hz, 2H), 7.25 – 7.20 (m, 1H), 7.14 (d, J = 7.9 Hz, 2H), 
6.81 (s, 1H), 6.38 (d, J = 0.7 Hz, 1H), 4.35 – 4.26 (m, 1H), 4.19 (dd, J = 17.2, 8.5 Hz, 1H), 3.91 
(td, J = 9.0, 5.4 Hz, 1H), 3.82 – 3.73 (m, 2H), 3.68 (t, J = 9.4 Hz, 1H), 3.63 – 3.56 (m, 1H), 3.14 
(ddd,J = 14.3, 10.0, 2.5 Hz, 1H), 2.86 (ddd, J = 14.3, 8.6, 1.3 Hz, 1H), 1.14 (d, J = 6.5 Hz, 12H), 
1.08 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 156.90 (C), 139.73 (C), 133.91 (CH), 129.06 (C), 
128.12 (CH), 127.54 (CH), 126.25 (CH), 116.58 (CH), 62.42 (CH2), 54.47 (C), 47.26 (CH), 46.87 
(CH2), 45.68 (CH), 29.27 (CH2), 21.31 (CH3), 20.38 (CH3), 18.64 (CH3). LRMS (ESI): 370 (M
+ + 
1), 270, 242, 181, 155, 126; HRMS calculated for C22H32N3O2 370.2489, found 370.2481. 
 In addition to nOe experiments (Figure S1), the structure and stereochemical identity of this 
adduct could be further corroborated by X-ray analysis (Figure S2).4 
        
Figure S1. nOe signals observed for Z-3aa. Figure S2. X-ray crystal structure of 3aa 
Other products isolated on the preliminary screening of Table 1 (manuscript)  
(1R,2Z,4R)-1-Methyl-2-[(2-oxo-1,3-oxazolidin-3-yl)methylene]-4-phenylcyclobutanecarbal 
dehyde diisopropylhydrazone (E-3aa).5 
                                                            
4 CCDC 1029359 contains the supplementary crystallographic data for this paper. These data can be obtained free of 
charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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1H NMR (300 MHz, CDCl3) δ 7.34 – 7.19 (m, 5H), 6.58 (s, 1H), 6.01 (dd, J = 
3.0, 2.2 Hz, 1H), 4.33 – 4.24 (m, 2H), 3.86 – 3.67 (m, 5H), 2.94 – 2.82 (m, 
1H), 2.69 (ddd, J = 15.8, 7.9, 3.1 Hz, 1H), 1.16 (d, J = 6.5 Hz, 6H), 1.11 (d, J 
= 6.5 Hz, 6H), 0.97 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 156.49 (C), 142.59 
(C), 140.02 (C), 132.78 (CH), 128.78 (CH), 127.85 (CH), 126.44 (CH), 
116.99 (CH), 61.92 (CH2), 55.17 (C), 54.70 (CH), 47.22 (CH), 45.86 (CH2), 
32.27 (CH2), 21.36 (CH3), 20.65 (CH3), 17.94 (CH3). LRMS (ESI): 370 (M
+ + 
1), 263, 242, 198, 155, 129, 100; HRMS calculated for C22H32N3O2 370.2489, found 370.2492. 
N
MePh
N(iPr)2
N
O
O
H
H
 
Figure S3. nOe signals observed for E-3aa 
3-((1S,4R,5R)-5-((E)-(2,2-Diisopropylhydrazono)methyl)-5-methyl-4-phenylcyclopent-2-en-1-
yl)oxazolidin-2-one (4aa).6 
NMR H (500 MHz, CDCl3) δ 6.45 (s, 1H), 6.28 (d, J = 5.9 Hz, 1H), 5.78 
(dt, J = 5.8, 2.8 Hz, 1H), 5.10 (dd, J = 4.2, 1.9 Hz, 1H), 4.25 – 4.21 (m, 
1H), 4.17 – 4.11 (m, 1H), 3.59 (ddd, J = 9.5, 8.5, 6.7 Hz, 2H), 3.49 – 3.39 
(m, 2H) 1.22 (d, J = 6.5 Hz, 6H), 1.19 (d, J = 6.5 Hz, 6H), 0.80 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ 140.08 (C), 130.32 (CH), 128.78 (CH), 128.72 
(CH), 127.80 (CH), 126.60 (CH), 126.39 (CH), 68.86 (CH), 62.17 (CH2), 52.98 (C), 52.78 (CH), 
46.90 (CH), 41.71 (CH2), 24.42 (CH3), 21.03 (CH3). LRMS (ESI): 370 (M
+ + 1), 328, 269, 225, 
202, 182, 155, 100; HRMS calculated for C22H32N3O2 370.2489, found 370.2486. 
(1E,5E)-2-Methylene-6-(2-oxo-1,3-oxazolidin-3-yl)-3-phenylhex-5-enal diisopropylhydrazone 
(6aa).7 
1H NMR (500 MHz, CDCl3) δ 7.30 (d, J = 7.2 Hz, 2H), 7.27 – 
7.22 (m, 2H), 7.15 (t, J = 7.2 Hz, 1H), 6.99 (s, 1H), 6.65 (d, J = 
14.3 Hz, 1H), 5.06 (d, J = 8.8 Hz, 2H), 4.73 (dt, J = 14.4, 7.2 Hz, 
1H), 4.36 (t, J = 8.3 Hz, 2H), 4.18 (t, J = 7.8 Hz, 1H), 3.76 (p, J = 
6.5 Hz, 2H), 3.63 – 3.52 (m, 2H), 2.73 (dt, J = 14.3, 7.3 Hz, 1H), 2.58 (dt, J = 14.4, 7.3 Hz, 1H), 
1.15 (d, J = 6.6 Hz, 6H), 1.03 (d, J = 6.5 Hz, 6H). 13C NMR (75 MHz, CDCl3) δ 155.4 (C), 150.0 
(C), 144.3 (C), 129.5 (CH), 128.3 (CH), 128.0 (CH), 125.9 (CH), 124.6 (CH), 111.9 (CH2), 110.1 
(CH), 62.0 (CH2), 47.1 (CH), 46.1 (CH), 42.5 (CH2), 35.0 (CH2), 20.9 (CH3), 20.7 (CH3). LRMS 
(m/z, ESI): 370.25, (M+H)+, 283.21, 241.17, 199.12, 182.10, 155.09, 126.06. HRMS Calculated 
for C22H32N3O2: 370.2489, found 370.2495.  
                                                                                                                                                                              
5 a) Isolated from the reactions catalyzed by PtCl2, PtBr2, AuCl or PicAuCl2, Table 1 (main manuscript), entries 1-5). b) 
As a general trend, besides nOe experiments and X-ray analysis, the assignment of the Z / E geometry of the exo-
enamide moiety could also be carried out on the bases of the 1H NMR chemical shifts of the enamide and hydrazone 
signals. We found that Z isomers have the enamide and hydrazone signals more deshielded than the corresponding E 
counterparts. In this particular case, chemical shifts for Z-3aa are = 6.81ppm (hydrazone) and 6.38 ppm (enamide), 
whereas for E-3aa are 6.58 ppm (hydrazone) and 6.01 ppm (enamide). 
6 Data deduced from a sample of 4aa slightly contaminated with E-3aa and 5aa (Table 1, entries 1-3). 
7 Obtained from the reaction catalyzed by PhPAuNTf2 (Table 1, entry 6) 
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Cycloadducts obtained following the general procedure with the catalyst Au1 (Table 2, 
manuscript) 
(1R,2Z,4S)-2-[(2-Oxo-1,3-oxazolidin-3-yl)methylene]-4-phenylcyclobutanecarbaldehyde 
diisopropylhydrazone (Z-3ab) 
 Yellow solid, 62% yield. 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.28 (m, 4H), 
7.24 – 7.19 (m, 1H), 6.71 (d, J = 6.7 Hz, 1H), 6.40 (q, J = 2.2 Hz, 1H), 4.34 
– 4.28 (m, 1H), 4.23 – 4.17 (m, 1H), 4.06 (td, J = 9.1, 5.4 Hz, 1H), 3.94 
(ddd, J = 9.4, 6.4, 2.8 Hz, 1H), 3.73 (hept, J = 6.5 Hz, 2H), 3.66 (q, J = 9.1 
Hz, 1H), 3.51 (dt, J = 9.3, 7.1 Hz, 1H), 3.19 – 3.12 (m, 1H), 2.81 (ddd, J = 
15.4, 7.4, 2.4 Hz, 1H), 1.11 (d, J = 6.7 Hz, 12H). 13C NMR (126 MHz, 
CDCl3) δ 156.71 (C), 144.53 (C), 131.12 (CH), 128.49 (CH), 126.52 (CH), 126.30 (CH), 123.51 
(C), 118.03 (CH), 62.56 (CH2), 54.14 (CH), 47.14 (CH), 45.60 (CH2), 41.84 (CH), 33.73 (CH2), 
20.97 (CH3), 20.61 (CH3). LRMS (ESI): 356 (M
+ + 1), 314, 256, 228, 167, 126, 100; HRMS 
calculated for C21H30N3O2 356.2333, found 356.2335. 
(1R,2S,4Z)-2-(4-Methoxyphenyl)-4-[(2-oxo-1,3-oxazolidin-3-yl)methylene]cyclobutanecarbalde 
hyde diisopropylhydrazone (3ac) 
Yellow solid, 88% yield. 1H NMR (500 MHz, CDCl3) δ, 7.21 (d, J = 8.6 
Hz, 2H), 6.85 (d, J = 8.6 Hz, 2H) , 6.70 (d, J = 6.8 Hz, 1H), 6.38 (d, J 
= 2.1 Hz, 1H), 4.30 (td, J = 8.9, 5.5 Hz, 1H), 4.19 (q, J = 8.5 Hz, 1H), 
4.05 (td, J = 9.1, 5.4 Hz, 1H), 3.90 – 3.85 (m, 1H), 3.79 (s, 3H), 3.68 
(hept, J = 6.5 Hz, 2H), 3.65 (q, J = 9.0 Hz, 1H), 3.44 (dd, J = 16.2, 7.1 
Hz, 1H), 3.15 – 3.08 (m, 1H), 2.76 (ddd, J = 15.3, 7.4, 2.3 Hz, 1H), 1.12 – 1.07 (m, 12H). 13C 
NMR (126 MHz, CDCl3) δ 158.12 (C), 156.68 (C), 136.62 (C), 131.33 (CH), 127.48 (CH), 
123.60 (C), 117.95 (CH), 113.86 (CH), 62.54 (CH2), 55.36 (CH3), 54.35 (CH), 47.12 (CH), 45.59 
(CH2), 41.20 (CH), 33.96 (CH2), 20.92 (CH3), 20.58 (CH3). LRMS (ESI): 386 (M
+ + 1), 286, 257, 
199, 167, 125, 100; HRMS calculated for C22H32N3O3 386.2438, found 386.2437. 
(1R,2S,4Z)-2-(4-Fluorophenyl)-4-[(2-oxo-1,3-oxazolidin-3-yl)methylene]cyclobutanecarbaldehy-
de diisopropylhydrazone (3ad) 
White solid, 55% yield. 1H NMR (500 MHz, CDCl3) δ 7.30 – 7.25 (m, 
2H), 7.05 – 6.99 (m, 2H), 6.71 (d, J = 6.7 Hz, 1H), 6.42 (q, J = 2.2 Hz, 
1H), 4.37 – 4.31 (m, 1H), 4.22 (dd, J = 17.2, 8.5 Hz, 1H), 4.06 (td, J = 
9.1, 5.4 Hz, 1H), 3.94 – 3.88 (m, 1H), 3.76 (hept, J = 6.5 Hz, 2H), 3.69 
(q, J = 9.2 Hz, 1H), 3.50 (dd, J = 16.2, 7.2 Hz, 1H), 3.20 – 3.13 (m, 
1H), 2.79 (ddd, J = 15.4, 7.5, 2.4 Hz, 1H), 1.13 (dd, J = 7.9, 6.6 Hz, 
12H). 13C NMR (126 MHz, CDCl3) δ161.50 (d, J = 244.2 Hz, C), 156.70 (C), 140.21 (C), 130.69 
(CH), 127.96 (d, J = 7.8 Hz, CH), 123.25 (C), 118.17 (CH), 115.22 (d, J = 21.2 Hz, CH), 62.57 
(CH2), 54.42 (CH), 47.16 (CH), 45.65 (CH2), 41.25 (CH), 33.90 (CH2), 20.96 (CH3), 20.63 (CH3). 
LRMS (ESI): 374 (M+ + 1), 274, 249, 207, 167, 126; HRMS calculated for C21H29FN3O2 
374.2238, found 374.2242. 
ON
N
H
N(iPr)23ac
MeO
O
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(1S,2Z,4R)-2-[(2-Oxo-1,3-oxazolidin-3-yl)methylene]-1,4-diphenylcyclobutanecarbaldehyde 
diisopropylhydrazone (Z-3ae)8 
Yellow oil. 1H NMR (500 MHz, C6D6) δ 7.39 (dd, J = 8.0, 0.9 Hz, 2H), 7.18 
(t, J = 7.7 Hz, 2H), 7.12 (s, 1H), 7.09 – 7.03 (m, 2H), 7.02 – 6.95 (m, 4H), 
6.31 (s, 1H), 3.67 (t, J= 9.0 Hz, 1H), 3.35 – 3.22 (m, 4H), 3.04 – 2.95 (m, 
2H), 2.74 (ddd, J = 14.9, 9.1, 1.6 Hz, 1H), 2.58 (td, J = 9.0, 6.4 Hz, 1H), 
0.82 (d, J = 6.6 Hz, 6H), 0.77 (d, J = 6.4 Hz, 6H). 13C NMR (126 MHz, 
C6D6) δ 156.24 (C), 147.34 (C), 140.12 (C), 128.83 (CH), 128.69 (CH), 128.49 (CH), 128.43 
(CH), 128.35 (CH), 127.14 (CH), 126.71 (CH), 120.66 (C), 119.36 (CH), 62.22 (C), 61.74 (CH2), 
53.61 (CH), 47.28 (CH), 45.03 (CH2), 29.76 (CH2), 21.22 (CH3), 20.52 (CH3). LRMS (ESI): 432 
(M+ + 1), 361, 345, 331; HRMS calculated for C27H34N3O2 432.2646, found 432.2655. 
(1S,2E,4R)-2-[(2-Oxo-1,3-oxazolidin-3-yl)methylene]-1,4-diphenylcyclobutanecarbaldehyde 
diisopropylhydrazone (E-3ae) 
Yellow oil. 1H NMR (300 MHz, CDCl3) δ 7.16 – 7.01 (m, 8H), 6.93 (s, 1H), 
6.84 (dd, J = 7.0, 2.5 Hz, 2H), 6.75 – 6.70 (m, 1H), 4.45 (t, J = 9.2 Hz, 1H), 
4.20 – 4.07 (m, 2H), 3.82 (dq, J = 12.8, 6.4 Hz, 2H), 3.64 (td, J = 8.6, 6.8 Hz, 
1H), 3.42 (td, J = 9.0, 5.5 Hz, 1H), 3.15 – 2.96 (m, 2H), 1.23 – 1.16 (m, 12H). 
LRMS (ESI): 432 (M+ + 1), 381, 353, 345, 331; HRMS calculated for 
C27H34N3O2 432.2646, found 432.2632. 
(1R,2S,4Z)-1,2-Dimethyl-4-[(2-oxo-1,3-oxazolidin-3-yl)methylene]cyclobutanecarbaldehyde diiso 
propylhydrazone (Z-3af)9 
Yellow oil. 1H NMR (500 MHz, CDCl3) δ 6.59 (s, 1H), 6.18 – 6.16 (m, 1H), 
4.26 (ddd, J = 9.0, 7.3, 3.7 Hz, 1H), 4.17 – 4.08 (m, 1H), 3.86 (td, J = 9.1, 
5.5 Hz, 1H), 3.68 (dt, J = 13.0, 6.5 Hz, 2H), 3.61 – 3.55 (m, 1H), 2.70 – 
2.63 (m, 1H), 2.40 – 2.26 (m, 2H), 1.31 (s, 3H), 1.09 (d, J = 6.5 Hz, 6H), 
1.05 (d, J = 6.5 Hz, 6H) , 0.99 (d, J = 6.8 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 159.96 (C), 135.44 (CH), 130.41 (C), 116.16 (CH), 62.39 (CH2), 51.96 (C), 47.15 (CH), 
46.90 (CH2), 36.06 (CH), 33.79 (CH2), 21.00 (CH3), 20.62 (CH3), 17.07 (CH3), 15.04 (CH3). 
LRMS (ESI): 308 (M+ + 1), 266, 221, 180, 126, 100;; HRMS calculated for C17H30N3O2 
308.2333, found 308.2332. 
 
Figure S4. nOe signals observed for Z-3af 
                                                            
8 The combined yield for the mixture of Z-3ae and E-3ae is 95% (Z/E ratio = 6:4). We could separate a small amount of 
the Z isomer that allowed its independent characterization. 
9 The combined yield for the mixture of Z-3af and E-3af is 87% (Z/E ratio = 8:2). We could separate a small amount of 
both isomers that allowed their independent characterization. 
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(1R,2S,4E)-1,2-Dimethyl-4-[(2-oxo-1,3-oxazolidin-3-yl)methylene]cyclobutanecarbaldehyde 
diisopropylhydrazone (E-3af) 
Yellow oil. 1H NMR (500 MHz, CDCl3) δ 6.47 (s, 1H), 5.83 (s, 1H), 4.30 – 
4.19 (m, 2H), 3.81 – 3.75 (m, 1H), 3.74 – 3.64 (m, 3H), 2.46 (ddd, J = 15.5, 
7.6, 3.2 Hz, 1H), 2.38 – 2.29 (m, 1H), 2.07 – 1.99 (m, 1H), 1.15 (s, 3H), 1.09 
(dd, J = 8.4, 6.7 Hz, 12H), 0.93 (d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 156.5 (C), 143.30 (C), 135.21 (CH), 117.68 (CH), 61.94 (CH2), 
53.96 (C), 47.34 (CH), 45.78 (CH2), 43.53 (CH), 35.90 (CH2), 21.19 (CH3), 
20.44 (CH3), 15.91 (CH3), 13.72 (CH3). LRMS (ESI): 308 (M
+ + 1), 266, 221, 
180, 126, 100, 86; HRMS calculated for C17H30N3O2 308.2333, found 308.2330. 
 
Figure S5. nOe signals observed for E-3af. 
(1S,2S,4Z)-2-Methyl-4-[(2-oxo-1,3-oxazolidin-3-yl)methylene]-1-phenylcyclobutanecarbaldehyde 
diisopropylhydrazone (Z-3ag).10 
Yellow oil. 1H NMR (300 MHz, CDCl3) δ 7.43 – 7.38 (m, 2H), 7.36 – 7.29 
(m, 2H), 7.24 – 7.17 (m, 1H), 6.96 (s, 1H), 6.53 (t, J = 2.0 Hz, 1H), 4.06 – 
3.84 (m, 2H), 3.76 (dq, J = 12.9, 6.5 Hz, 2H), 3.60 (hept, J = 9.4, 1H), 2.99 
– 2.80 (m, 2H), 2.65 – 2.51 (m, 1H), 2.30 (ddd, J = 14.5, 7.8, 2.4 Hz, 1H), 
1.15 (d, J = 6.5 Hz, 3H), 1.10 (d, J = 6.6 Hz, 12H). 13C NMR (75 MHz, 
CDCl3) δ 156.72 (C), 147.00 (C), 128.79 (CH), 128.47 (CH), 126.65 (CH), 
126.31 (CH), 123.81 (C), 117.45 (CH), 62.56 (CH2), 59.64 (C), 47.39 (CH), 45.18 (CH2), 43.73 
(CH), 33.46 (CH2), 21.53 (CH3), 20.63 (CH3), 17.00 (CH3). LRMS (ESI): 370 (M
+ + 1), 270, 242, 
182, 155, 126, 100; HRMS calculated for C22H32N3O2 370.2489, found 370.2485. 
(1S,2S,4E)-2-Methyl-4-[(2-oxo-1,3-oxazolidin-3-yl)methylene]-1-phenylcyclobutanecarbaldehy-
de diisopropylhydrazone (E-3ag) 
Yellow oil. 1H NMR (300 MHz, CDCl3) δ 7.36 – 7.19 (m, 5H), 6.92 (s, 1H), 
6.08 – 6.05 (m, 1H), 4.12 (t, J = 8.0 Hz, 2H), 3.77 (dt, J = 13.0, 6.5 Hz, 2H), 
3.61 (dd, J = 16.4, 8.5 Hz, 1H), 3.26 (dd, J = 17.0, 8.2 Hz, 1H), 3.13 (dd, J = 
16.1, 7.5 Hz, 1H), 2.55 (ddd, J = 15.8, 7.7, 3.1 Hz, 1H), 1.95 (ddd, J = 15.8, 
9.0, 2.1 Hz, 1H), 1.18 – 1.10 (m, 12H), 0.55 (d, J = 7.0 Hz, 3H). 13C NMR 
(75 MHz, CDCl3) δ 156.27 (C), 140.32 (C), 132.97 (CH), 128.13 (CH), 
                                                            
10 The combined yield for the mixture of Z-3ag and E-3ag is 94% (Z/E ratio = 6:4). We could separate a small amount of 
both isomers that allowed their independent characterization. 
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126.51 (CH), 119.31 (CH), 62.34 (CH2), 61.97 (C), 47.41 (CH), 46.03 (CH2), 44.20 (CH), 36.18 
(CH2), 21.10 (CH3), 20.94 (CH3), 16.63 (CH3). LRMS (ESI): 370 (M
+ + 1), 328, 283, 242, 198, 
155, 126, 100; HRMS calculated for C22H32N3O2 370.2489, found 370.2487. 
(1R,2S,4Z)-2-Methyl-4-[(2-oxo-1,3-oxazolidin-3-yl)methylene]cyclobutanecarbaldehyde diisopro 
pylhydrazone (Z-3ah) 
Yellow oil, 95% yield. 1H NMR (500 MHz, CDCl3) δ 6.62 (d, J = 6.9 Hz, 
1H), 6.27 (t, J = 3.7 Hz, 1H), 4.28 (td, J = 8.9, 5.5 Hz, 1H), 4.16 (q, J = 8.7 
Hz, 1H), 4.04 – 3.99 (m, 1H), 3.70 – 3.62 (m, 3H), 3.37 – 3.31 (m, 1H), 
2.88 – 2.81 (m, 1H), 2.33 – 2.26 (m, 1H), 2.18 – 2.12 (m, 1H), 1.18 (dd, J 
= 6.8, 2.4 Hz, 3H), 1.07 (d, J = 6.6 Hz, 6H), 1.03 (d, J = 6.6 Hz, 6H). 13C 
NMR (126 MHz, CDCl3) δ 156.53 (C), 133.25 (CH), 123.40 (C), 118.05 (CH), 62.45 (CH2), 53.35 
(CH), 47.07 (CH), 45.28 (CH2), 34.16 (CH2), 32.50 (CH), 20.66 (CH3), 20.65 (CH3), 20.63 (CH3). 
LRMS (ESI): 294 (M+ + 1), 252, 207, 166, 126; HRMS calculated for C16H28N3O2 294.2176, 
found 294.2179. 
 
Figure S6. nOe signals observed for E-3ah 
(1R,6S,8Z)-8-[(2-Oxo-1,3-oxazolidin-3-yl)methylene]bicyclo[4.2.0]octane-1-carbaldehyde 
diisopropylhydrazone (Z-3ai)11 
Yellow oil. 1H NMR (500 MHz, CDCl3) δ 6.50 (s, 1H), 6.14 (s, 1H), 4.26 (td, 
J = 8.9, 5.3 Hz, 1H), 4.13 (q, J = 8.6 Hz, 1H), 3.85 (td, J = 9.1, 5.3 Hz, 1H), 
3.70 (hept,J = 6.5 Hz, 2H), 3.50 (q, J = 9.1 Hz, 1H), 2.65 – 2.54 (m, 2H), 
2.47 (ddd, J = 14.0, 8.8, 0.7 Hz, 1H), 2.42 – 2.34 (m, 1H), 1.64 – 1.39 (m, 
6H), 1.28 – 1.18 (m, 1H), 1.09 (d, J = 6.6 Hz, 6H), 1.08 (d, J = 6.5 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 157.03 (C), 133.41 (CH), 131.89 (C), 115.15 (CH), 62.47 (CH2), 
50.93 (C), 47.19 (CH), 47.11 (CH2), 36.70 (CH), 29.93 (CH2), 29.24 (CH2), 25.33 (CH2), 21.56 
(CH2), 21.16 (CH3), 21.08 (CH2), 20.64 (CH3). LRMS (ESI): 334 (M
+ + 1), 292, 247, 206, 162, 
119, 100; HRMS calculated for C19H32N3O2 334.2489, found 334.2493. 
 
Figure S7. nOe signals observed for Z-3ai 
                                                            
11 The combined yield for the mixture of Z-3ai and E-3ai is 90% (Z/E ratio = 7:3). We could separate a small amount of 
both isomers that allowed their independent characterization. 
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(1R,6S,8E)-8-[(2-Oxo-1,3-oxazolidin-3-yl)methylene]bicyclo[4.2.0]octane-1-carbaldehyde 
diisopropylhydrazone (E-3ai) 
Yellow oil. 1H NMR (500 MHz, CDCl3) δ 6.42 (s, 1H), 5.75 (s, 1H), 4.28 
– 4.16 (m, 2H), 3.85 (ddd, J = 9.0, 7.9, 4.7 Hz, 1H), 3.74 – 3.59 (m, 
3H), 2.45 – 2.37 (m, 2H), 2.33 – 2.27 (m, 2H), 1.61 – 1.56 (m, 1H), 1.54 
– 1.33 (m, 6H),1.11 – 1.07 (m, 12H). 13C NMR (126 MHz, CDCl3) δ 
156.40 (C), 144.85 (C), 133.64 (CH), 117.41 (CH), 61.92 (CH2), 52.85 
(C), 47.23 (CH), 45.85 (CH2), 44.63 (CH), 32.21 (CH2), 30.92 (CH2), 
25.96 (CH2), 21.64 (CH2), 21.48 (CH2), 21.13 (CH3), 20.74 (CH3). LRMS (ESI): 334 (M
+ + 1), 
292, 247, 206, 162, 119, 100; HRMS calculated for C19H32N3O2 334.2489, found 334.2491. 
5-[(2E)-3-(2-Oxo-1,3-oxazolidin-3-yl)prop-2-en-1-yl]cyclopent-1-ene-1-carbaldehyde diisopropyl 
hydrazone (6aj) 
Yellow oil, 65% yield, 1H NMR  (500 MHz, CDCl3) δ 7.16 (s, 1H), 6.65 
(d, J = 14.6 Hz, 1H), 5.59 (s, 1H), 4.80 (dt,J = 14.6, 7.5 Hz, 1H), 4.43 
– 4.38 (m, 2H), 3.83 – 3.75 (m, 2H), 3.69 (dd, J = 8.8, 7.4 Hz, 2H), 
3.14 – 3.07 (m, 1H), 2.56 (dddd, J = 13.7, 7.3, 3.3, 1.1 Hz, 1H), 2.41 
– 2.26 (m, 2H), 2.24 – 2.17 (m, 1H), 1.97 (ddd, J = 17.1, 12.9, 9.1 Hz, 
1H), 1.75 – 1.67 (m, 1H), 1.14 (d, J = 6.5 Hz, 12H). 13C NMR (75 MHz, CDCl3) δ 155.53 (C), 
146.10 (C), 127.09 (CH), 125.67 (CH), 124.38 (CH), 110.45 (CH), 62.18 (CH2), 47.12 (CH), 
44.25 (CH), 42.84 (CH2), 33.64 (CH2), 31.46 (CH2), 28.75 (CH2), 21.22 (CH3), 20.96 (CH3). 
LRMS (ESI): 320 (M+ + 1), 278, 233, 191, 126; HRMS calculated for C18H30N3O2  320.2333, 
found 320.2332. 
Ethyl (1S,2R,3Z/E)-2-[(E)-(diisopropylhydrazono)methyl]-2-methyl-3-[(2-oxo-1,3-oxazolidin-3-
yl)methylene]cyclobutanecarboxylate (3ak).12 
Yellow oil, 83% yield. 1H NMR (500 MHz, CDCl3)  δ 6.60 (s, 0.62H), 
6.50 (s, 0.38H), 6.26 (d, J = 2.0 Hz, 0.62H), 5.76 (dd, J = 2.8, 2.2 Hz, 
0.38H), 4.32 – 4.03 (m, 4H), 3.82 (td, J = 9.1, 5.6 Hz, 0.62H), 3.78 – 
3.66 (m, 2.8H), 3.56 (dd, J = 17.3, 9.1 Hz, 0.62H), 3.32 (dd, J = 9.3, 8.6 
Hz, 0.38H), 3.18 – 3.07 (m, 1.24H), 2.83 (ddd, J = 16.3, 9.6, 2.0 Hz, 
0.38H), 2.60 (ddd, J = 14.5, 7.9, 1.4 Hz, 0.62H), 2.48 (ddd, J = 16.2, 
8.3, 3.1 Hz, 0.38H), 1.39 (s, 2H), 1.26 (s, 1H), 1.24 – 1.18 (m, 3H), 1.13 – 1.06 (m, 12H). 13C 
NMR (126 MHz, CDCl3) δ 172.56 (C), 172.00 (C), 156.58 (C), 156.55 (C), 132.74 (CH), 132.03 
(CH), 126.85 (C), 117.15 (CH), 115.94 (CH), 62.24 (CH2), 61.84 (CH2), 60.31 (CH2), 60.23 
(CH2), 54.03 (CH), 53.72 (C), 47.20 (CH2), 47.17 (CH2),  45.77 (CH2), 44.73 (CH), 29.61 (CH2), 
27.17 (CH2), 21.21 (CH3), 21.13 (CH3), 20.36 (CH3), 20.22 (CH3), 18.69 (CH), 17.73 (CH), 14.38 
(CH3), 14.26 (CH3). LRMS (ESI): 366, 324, 279, 238, 181, 164, 126; HRMS calculated for 
C19H32N3O4 366.2386, found 366.2387. 
 
 
                                                            
12 Z and E isomers of 3ak could not be separated by standard column chromatography techniques. 
S15 
 
(1R,2Z,4R)-1-Methyl-2-[(2-oxo-1,3-oxazolidin-3-yl)methylene]-4-phenylcyclobutanecarbaldehy-
de dimethylhydrazone (3aa’) 
Yellow solid, 76% yield. 1H NMR (400 MHz, CDCl3) δ 7.29 (q, J = 7.3 Hz, 
2H), 7.21 (t, J = 7.3 Hz, 1H), 7.12 (d, J = 7.6 Hz, 2H), 6.85 (s, 1H), 6.36 (s, 
1H), 4.33 – 4.20 (m, 2H), 3.86 – 3.78 (m, 1H), 3.68 (t, J = 9.4 Hz, 1H), 3.57 
(dd, J = 16.9, 9.0 Hz, 1H), 3.13 – 3.10  (m, 1H), 2.87 (dd, J = 14.6, 8.8 Hz, 
1H), 2.79 (s, 6H), 1.05 (s, 3H). 13C NMR(101 MHz, CDCl3) δ 156.78 (C), 
141.58 (CH), 139.19 (C), 128.16 (CH), 127.93 (C), 127.60 (CH), 126.45 
(CH), 117.07 (CH), 62.19 (CH2), 53.42 (C), 46.74 (CH2), 45.29 (CH), 43.37 (CH3), 29.35 (CH2), 
18.58 (CH3). LRMS (CI): 314.1 (M
+ + 1), 227, 182, 126. HRMS calculated for C18H24N3O2 
314.1869, found 314.1860. 
(1E,5E)-2-Methylene-6-(2-oxo-1,3-oxazolidin-3-yl)-3-phenylhex-5-enal dimethylhydrazone (6aa’) 
6% yield. 1H NMR (400 MHz, CDCl3) δ 7.35 – 7.27 (m, 4H), 7.23 – 
7.16 (m, 1H), 6.94 (s, 1H), 6.68 (d, J = 14.3 Hz, 1H), 5.22 (s, 1H), 
5.21 (s, 1H), 4.75 (dt, J = 14.3, 7.2 Hz, 1H), 4.36 (t, J = 8.1 Hz, 
2H), 4.17 (t, J = 7.8 Hz, 1H), 3.61 – 3.54 (m, 2H), 2.85 (s, 6H), 
2.81 – 2.70 (m, 1H), 2.67 – 2.57 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 155.39 (C), 148.79 (C), 
143.79 (C), 134.93 (CH), 128.30 (CH), 128.06 (CH), 126.01 (CH), 124.71 (CH), 114.29 (CH2), 
109.74 (CH), 62.10 (CH2), 45.95 (CH), 42.69 (CH3), 42.58 (CH2), 34.75 (CH2). LRMS (ESI): 314 
(M+ + 1), 182, 111. HRMS calculated for C18H24N3O2 314.1869, found 314.1875. 
(1R,2Z,4S)-2-[(2-Oxo-1,3-oxazolidin-3-yl)methylene]-4-phenylcyclobutanecarbaldehyde dime-
thylhydrazone (3ab’) 
Yellow oil, 53% yield. 1H NMR (500 MHz, CDCl3) δ 7.26 – 7.19 (m, 4H), 
7.16 – 7.11 (m, 1H), 6.66 (d, J = 7.2 Hz, 1H), 6.33 (q, J = 2.3 Hz, 1H), 4.27 
– 4.16 (m, 2H), 3.91 – 3.83 (m, 2H), 3.59 (dd, J = 16.9, 9.2 Hz, 1H), 3.45 – 
3.40 (m, 1H), 3.13 – 3.06 (m, 1H), 2.80 – 2.73 (m, 1H), 2.69 (s, 6H). 13C 
NMR (126 MHz, CDCl3) δ 156.61 (C), 143.77 (C), 137.81 (CH), 128.53 
(CH), 126.58 (CH), 126.52 (CH), 122.12 (C), 118.60 (CH), 62.43 (CH2), 53.30 (CH), 45.57 
(CH2), 43.18 (CH3), 41.81 (CH), 34.13 (CH2). LRMS (CI): 300.1 (M
+ + 1), 255, 213, 126, 111. 
HRMS calculated for C17H22N3O2 300.1712, found 300.1714. 
(1R,2S,4Z)-2-(4-Methoxyphenyl)-4-[(2-oxo-1,3-oxazolidin-3-yl)methylene]cyclobutanecarbalde-
hyde dimethylhydrazone (3ac’) 
Yellow solid, 41% yield. 1H NMR (500 MHz, CDCl3) δ 7.25 – 7.21 (m, 
2H), 6.90 – 6.87 (m, 2H), 6.75 (d, J = 7.3 Hz, 1H), 6.44 – 6.41 (m, 
1H), 4.38 – 4.26 (m, 2H), 3.99 – 3.94 (m, 1H), 3.93 – 3.88 (m, 1H), 
3.81 (s, 3H), 3.69 (dd, J = 17.0, 9.2 Hz, 1H), 3.49 – 3.43 (m, 1H), 3.20 
– 3.13 (m, 1H), 2.85 – 2.80 (m, 1H), 2.79 (s, 6H). 13C NMR (126 MHz, 
CDCl3) δ 158.35 (C), 156.68 (C), 138.23 (CH), 135.94 (C), 127.64 
(CH), 122.36 (C), 118.58 (CH), 113.99 (CH), 62.48 (CH2), 55.43 (CH), 53.61 (CH), 45.66 (CH2), 
43.26 (CH3), 41.28 (CH3), 34.46 (CH2). LRMS (CI): 330.1 (M
+ + 1), 286, 243, 198, 111, 88. 
HRMS calculated for C18H24N3O3 329.1818, found 330.1819. In addition to nOe experiments, the 
ON
N
MePh
NMe23aa'
O
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structure and stereochemical identity of this adduct could be further corroborated by X-ray 
analysis (Figure S8).13 
  
Figure S8. X-ray structure of 3ac’ 
(1R,2S,4Z/E)-1,2-Dimethyl-4-[(2-oxo-1,3-oxazolidin-3-yl)methylene]cyclobutanecarbaldehyde 
dimethylhydrazone (3af’) 
White solid, 47% yield.14 1H NMR (500 MHz, CDCl3) δ 6.70 (s, 0.18H), 6.65 
(s, 0.82H), 6.25 (t, J = 2.0 Hz, 0.18H), 6.19 (t, J = 1.9 Hz, 0.82H), 4.32 – 
4.19 (m, 2H), 3.81 – 3.63 (m, 2H), 3.61 – 3.55 (m, 2H), 2.74 (s, 1.08H), 
2.72 (s, 4.92H), 2.42 – 2.29 (m, 2H), 1.43 (s, 0.54H), 1.31 (s, 2.46H), 1.03 
(d, J = 7.0 Hz, 0.54H), 1.00 (d, J = 6.8 Hz, 2.46H). 13C NMR (101 MHz, 
CDCl3) δ 156.90, 142.47, 129.35, 117.79, 116.60, 62.24, 50.90, 46.80, 43.54, 43.39, 35.74, 
33.80, 33.16, 24.53, 17.03, 16.86, 14.94, 13.61. LRMS (CI): 252.1 (M+ + 1), 207, 165, 126, 116, 
88. HRMS calculated for C13H22N3O2 252.1712, found 251.1710. 
3-((E)-5-((E)-(2,2-dimethylhydrazono)methyl)-4-methylhexa-1,5-dien-1-yl)oxazolidin-2-one (6af’) 
White solid. 21% yield. 1H NMR (500 MHz, CDCl3) δ 6.95 (s, 
1H), 6.61 (d, J = 14.3 Hz, 1H), 5.08 – 5.04 (m, 2H), 4.80 – 4.73 
(m, 1H), 4.43 – 4.37 (m, 2H), 3.67 (dd, J = 14.7, 6.1 Hz, 2H), 
2.95 – 2.87 (m, 1H), 2.84 (s, 6H), 2.38 – 2.29 (m, 1H), 2.19 – 
2.09 (m, 1H), 1.07 (dd, J = 7.0, 0.8 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 155.53 (C), 150.89 
(C), 136.17 (CH), 124.58 (CH), 113.52 (CH2), 110.05 (CH), 62.19 (CH2), 42.93 (CH3), 42.80 
(CH2), 36.32 (CH2), 34.04 (CH), 19.43 (CH3). LRMS (CI): 252.1 (M
+ + 1), 207, 180, 165, 126, 
59. HRMS calculated for C13H22N3O2 252.1712, found 251.1711. 
Ethyl (1S,2R,Z)-2-((E)-(2,2-dimethylhydrazono)methyl)-2-methyl-3-((2-oxooxazolidin-3-yl)methy 
lene)cyclobutane-1-carboxylate (3ak’) 
Yellow oil, 63% yield. 1H NMR (500 MHz, CDCl3) δ 6.66 (s, 1H), 6.29 – 
6.27 (m, 1H), 4.34 – 4.22 (m, 2H), 4.20 – 4.11 (m, 2H), 3.83 – 3.77 (m, 
1H), 3.60 – 3.54 (m, 1H), 3.21 – 3.10 (m, 3H), 2.77 (s, 6H), 2.69 – 2.63 
(m, 1H), 1.39 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 171.92 (C), 156.72 (C), 139.48 (CH), 126.33 (C), 117.88 (CH), 
                                                            
13 CCDC 1029358 contains the supplementary crystallographic data for this paper. These data can be obtained free of 
charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
14 Z : E ratio =  0.93: 0.07, (1H NMR of the crude mixture) Z : E ratio =  0.82 : 0.18 after column chromatography. The 
isomers could not be separated. 
O N
N-NMe2
O
Me
6af'
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62.24 (CH2), 60.70 (CH2), 52.73 (C), 46.64 (CH2), 44.45 (CH), 43.24 (CH3), 27.42 (CH2), 18.89 
(CH3), 14.56 (CH3). LRMS (CI): 310 (M
+ + 1), 299.1, 223.1, 126.1, 88.0. HRMS calculated for 
C15H24N3O4 310.1767 found 310.1768. 
3-((Z)-((2R,3R)-2-((E)-(((S)-2-(methoxymethyl)pyrrolidin-1-yl)imino)methyl)-2-methyl-3-phenylcy 
clobutylidene)methyl)oxazolidin-2-one (3aa’’) 
Yellow oil, 85% yield, dr = 7: 3. 1H NMR  (500 MHz, CDCl3) δ7.38 – 7.28 
(m, 2H), 7.24 (t, J = 7.3 Hz, 1H), 7.18 – 7.14 (m, 2H), 6.87 (s, 0.7H), 6.83 
(s, 0.3H), 6.39 (s, 0.7H), 6.38 (s, 0.3H), 4.38 – 4.22 (m, 3H), 4.01 – 3.87 (m, 
2H), 3.75 – 3.66 (m, 1H), 3.64 – 3.54 (m, 2H), 3.53 – 3.45 (m, 2H), 3.44 – 
3.40 (m, 1H), 3.39 (s, 2.1H), 3.36 (s, 0.9H), 3.19 – 3.11 (m, 0.3H), 2.91 – 
2.82 (m, 0.7H),  2.08 – 1.92 (m, 2.8H), 1.90 – 1.80 (m, 1.2H), 1.07 (s, 2.1H), 
1.04 (s, 0.9H). 13C NMR (126 MHz, CDCl3) δ 141.36 (CH), 141.00 (CH), 
139.37 (C), 128.57 (C), 128.14 (CH), 128.02 (C), 127.90 (C), 127.72 (C), 
127.66 (CH), 126.43 (CH), 116.99 (CH), 74.78 (CH2), 74.55 (CH2), 63.35 (CH3), 62.35 (CH2), 
62.21 (CH2), 59.69 (CH), 59.53 (CH), 53.60 (C), 46.82 (CH2), 46.79 (CH2), 45.66, 45.28, 29.33 
(CH2), 29.25 (CH2), 26.72 (CH2), 26.55 (CH2), 22.23 (CH2), 22.12 (CH2), 18.88 (CH3), 18.75 
(CH3). LRMS (ESI): 384 (M
+ + 1), 297, 270, 242, 195, 155, 129; HRMS calculated for 
C22H30N3O3 384.2282, found 384.2270. 
3-((Z)-((2R,3S)-2-((E)-(((S)-2-(methoxymethyl)pyrrolidin-1-yl)imino)methyl)-2,3-dimethylcyclo 
butylidene)methyl)oxazolidin-2-one (3af’’) 
Yellow oil, 63% yield, dr =  6 : 4. 1H NMR (500 MHz, CDCl3) δ6.66 (s, 
0.6H), 6.60 (s, 0.4H), 6.20 – 6.18 (m, 1H), 4.33 – 4.09 (m, 2H), 3.92 – 
3.81 (m, 2H), 3.62 – 3.53 (m, 3H), 3.45 – 3.39 (m, 1H), 3.36 (s, 1.8H), 
3.34 (s, 1.2H), 2.77 – 2.66 (m, 2H), 2.43 – 2.27 (m, 2H), 2.00 – 1.85 (m, 
3H), 1.83 – 1.74 (m, 1H), 1.30 (s, 1.8H), 1.30 (s, 1.2H), 1.00 (d, J = 6.8 
Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 156.85 (C), 142.44 (CH), 141.61 
(CH), 129.64 (C), 129.06 (C), 116.48 (CH), 74.87 (CH2), 74.59 (CH2), 
63.49 (CH3), 63.35 (CH3), 62.31 (CH2), 62.15 (CH2), 59.32 (CH), 59.21 
(CH), 51.07 (C), 50.06 (C), 49.83 (CH2), 46.88 (CH2), 46.73 (CH2), 35.84 (CH), 35.70 (CH), 
33.68 (CH2), 26.71 (CH2), 26.58 (CH2), 22.24 (CH2), 22.19 (CH2), 17.11 (CH3), 14.99 (CH3), 
14.92 (CH3). LRMS (ESI): 321 (M
+ + 1), 235, 180, 126; HRMS calculated for C17H27N3O3 
321.2125, found 321.2131. 
N-((Z)-((2R,3R)-2-((E)-(2,2-diisopropylhydrazono)methyl)-2-methyl-3-phenylcyclobutylidene) 
methyl)-4- methyl-N-phenylbenzenesulfonamide (3ba) 
95% yield. 1H NMR (300 MHz, CDCl3) δ 7.47 (d, J = 8.2 Hz, 2H), 7.35 – 
7.15 (m, 10H), 7.12 – 7.04 (m, 2H), 6.78 (s, 1H), 6.19 – 6.16 (m, 1H), 3.98 
(t, J = 9.1 Hz, 1H), 3.81 – 3.68 (m, 2H), 3.03 (ddd, J = 14.6, 9.6, 2.3 Hz, 
1H), 2.95 – 2.83 (m, 1H), 2.44 (s, J = 8.1 Hz, 3H), 1.23 (d, J = 6.5 Hz, 6H), 
1.13 (d, J = 6.4 Hz, 6H), 0.51 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 144.40 
(C), 143.69 (C), 142.61 (C), 140.32 (C), 134.34 (C), 133.04 (CH), 129.44 (CH), 128.60 (CH), 
127.92 (CH), 127.81 (CH), 127.66 (CH), 126.85 (CH), 125.94 (CH), 119.32 (CH), 55.19 (C), 
47.01 (CH), 43.19 (CH), 29.30 (CH2), 21.68 (CH3), 21.41 (CH3), 20.43 (CH3), 17.01 (CH3). 
S18 
 
LRMS (ESI): 530, 457, 381, 353; HRMS calculated for C32H40N3O2S2 530.2836, found 
530.2835. 
 
Figure S9. nOe signals observed for 3ba 
N-((Z)-{(2R,3S)-2-[(E)-(diisopropylhydrazono)methyl]-3-phenylcyclobutylidene}methyl)-4-methyl-
N-phenylbenzenesulfonamide (3bb) 
97% yield. 1H NMR (300 MHz, CDCl3) δ 7.50 (d, J = 8.1 Hz, 2H), 7.31 – 
7.14 (m, 10H), 7.09 (d, J = 9.1 Hz, 2H), 6.37 – 6.32 (m, 1H), 3.79 (q, J = 8.4 
Hz, 1H), 3.69 – 3.60 (m, 2H), 3.32 – 3.24 (m, 1H), 3.12 – 3.00 (m, 1H), 2.77 
(ddd, J = 15.0, 8.5, 2.3 Hz, 1H), 2.44 (d, J = 5.2 Hz, 3H), 1.11 (dd, J = 8.8, 
6.6 Hz, 12H), 0.10 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 144.93 (C), 
143.76 (C), 140.25 (C), 135.20 (C), 134.12 (C), 129.56 (CH), 128.74 (CH), 128.42 (CH), 128.24 
(CH), 128.09 (CH), 127.8 1(CH), 127.25 (CH), 126.69 (CH), 125.95 (CH), 119.90 (CH), 54.21 
(CH), 46.99 (CH), 39.91 (CH), 33.30 (CH2), 21.73 (CH3), 21.20 (CH3), 20.63 (CH3). LRMS (ESI): 
516, 457, 381, 353; HRMS calculated for C31H38N3O2S2 516.2679, found 516.2669. 
(1R,4R,Z)-1-Methyl-2-((2-oxooxazolidin-3-yl)methylene)-4-phenylcyclobutane-1-carbo nitrile 
(7a). 
 
Magnesium monoperoxiphthalate (MMPP, 73.6 mg, 1.49 mmol) was added to a solution of 3aa 
(50 mg, 0.14 mmol) in EtOH (2 ml) at 0ºC. After stirring for 5 min, a solution of Na2SO3 (sat) (2 
ml) was added and the mixture was extracted with CH2Cl2 (2 x 5 ml). The combined organic 
phases were subsequently washed with NaHCO3 (5 ml) and NaCl (5 ml), dried and 
concentrated to afford a crude residue that was purified on column chromatography 
(hexanes:Et2O = 9:1), to yield 23.3 mg of 7a (64 % yield). 
1H NMR (300 MHz, CDCl3) δ 7.47 – 
7.31 (m, 3H), 7.30 – 7.24 (m, 2H), 6.54 (dd, J = 5.7, 3.6 Hz, 1H), 4.52 – 4.43 (m, 2H), 4.39 – 
4.29 (m, 1H), 4.21 (t, J = 9.6 Hz, 1H), 3.96 – 3.86 (m, 1H), 3.27 (ddd, J = 15.1, 10.0, 2.5 Hz, 
1H), 3.02 (ddd, J = 15.1, 9.3, 1.6 Hz, 1H), 1.25 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 156.28 (C), 
136.11 (C), 128.81 (CH), 127.94 (CH), 127.88 (CH), 123.97 (C), 119.73 (CH), 117.49 (C), 62.32 
(CH2), 45.61 (CH2), 45.33 (CH), 40.33 (C), 29.59 (CH2), 21.42 (CH3). LRMS (CI): 268 (M
+ ). 
HRMS calculated for C16H17N2O2  268.1212, found 268.1205. 
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(1R,2S,5S,6R)-5-Methyl-6-phenyl-3-oxabicyclo[3.2.0]heptane-1,2-diol (9a) 
 
HCl 1M (0.16 ml, 1.37 mmol) was added to a solution of 3aa’ (50 mg, 1.37 mmol) in Et2O (2.3 
ml) and the mixture was stirred for 5 min at rt. The mixture was poured into brine (10 ml), 
extracted with Et2O and dried. The solvent was removed under reduced pressure and the crude 
residue was chromatographed on silica gel (hexanes:Et2O 8:2), to yield 39 mg of the 
corresponding aldehyde (90 % yield). (1R,4R,Z)-1-methyl-2-((2-oxooxazolidin-3-yl)methylene)-
4-phenylcyclobutane-1-carbal dehyde. 1H NMR (500 MHz, CDCl3) δ 9.88 (s, 1H), 7.36 (t, J = 7.6 
Hz, 2H), 7.31 – 7.26 (m, 1H), 7.12 (d, J = 7.4 Hz, 2H), 6.57 (t, J = 2.0 Hz, 1H), 4.35 (t, J = 8.0 
Hz, 2H), 3.98 (t, J = 9.1 Hz, 1H), 3.65 – 3.54 (m, 2H), 3.32 (ddd, J = 15.1, 9.1, 2.4 Hz, 1H), 3.06 
(ddd, J = 15.2, 9.2, 1.6 Hz, 1H), 1.04 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 200.78 (CH), 156.33 
(C), 137.49 (C), 128.49 (CH), 127.94 (CH), 127.14 (CH), 119.88 (CH), 119.29 (C), 62.08 (CH2), 
60.65 (C), 45.28 (CH2), 39.96 (CH), 30.46 (CH2), 15.81 (CH3). LRMS (ESI): 271 (M
+ + 1); 
HRMS calculated for C16H17NO3  271.1208, found 271.1204
.  
NaBH4 (0.013 g, 0.350 mmol) was added to a solution of (Z)-1-methyl-2-((2-oxooxazolidin-3-
yl)methylene)-4-phenylcyclobutanecarbaldehyde (38 mg, 0.140 mmol) in MeOH (2 ml). After 
stirring at rt for 5 min, acetone and water were successively added to the reaction mixture. After 
extraction with Et2O (3 x 5 ml) the combined organic phases were dried and evaporated to 
afford a crude residue that was chromatographed (hexanes/EtOAc, 1:1) to give 8a (29.2 mg, 
0.107 mmol, 76 % yield). 3-((Z)-((2R,3R)-2-(hydroxymethyl)-2-methyl-3-phenylcyclobutylidene) 
methyl)oxazolidin-2-one (8a). 1H NMR (300 MHz, CDCl3) δ 7.36 – 7.27 (m, 2H), 7.25 – 7.14 (m, 
3H), 5.99 (t, J = 2.1 Hz, 1H), 4.45 – 4.30 (m, 2H), 3.86 – 3.65 (m, 4H), 3.63 – 3.54 (m, 1H), 3.15 
(t, J = 6.4 Hz, 1H), 3.09 – 2.85 (m, 2H), 0.78 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 158.08 (C), 
139.99 (C), 139.21 (C), 128.11 (CH), 127.97 (CH), 126.31 (CH), 116.94 (CH), 68.57 (CH2), 
62.24 (CH2), 53.90 (C), 46.83 (CH2), 40.36 (CH), 29.03 (CH2), 18.16 (CH3). LRMS (m/z, ESI): 
269.13 (M+Na)+, 256.13, 212.14, 169.10, 154.08, 105.05. HRMS Calculated for C16H19NNaO3: 
296.1257, found 296.1258.  
H2O (141 µl), NMO (21.43 mg, 0.183 mmol) and OsO4 (4%wt  solution in H2O, 29.1 µl, 4.57 
µmol) were added successively to a stirred solution of (Z)-3-((2-(hydroxymethyl)-2-methyl-3-
phenylcyclobutylidene) methyl)oxazolidin-2-one (25 mg, 0.091 mmol) in acetone:acetonitrile 1:1 
(0.3mL). After being stirred at rt for 3h, the reaction mixture was quenched with Na2S2O3 sat (2 
ml) and further stirred for 30 min. After extraction with CH2Cl2, the organic phases were dried 
and evaporated to afford a crude residue that was chromatographed (hexanes/EtOAc 10-50%) 
to give 9a (12.2 mg 61% yield).  (1R,2S,5S,6R)-5-methyl-6-phenyl-3-oxabicyclo[3.2.0]heptane-
1,2-diol (9a). 1H NMR (500 MHz, CDCl3) δ 7.32 (t, J = 7.5 Hz, 2H), 7.25 – 7.17 (m, 3H), 5.39 (s, 
1H), 3.93 (d, J = 8.9 Hz, 1H), 3.84 (d, J = 8.9 Hz, 1H), 3.48 (s, 1H), 3.17 (t, J = 9.2 Hz, 1H), 3.12 
(s, 1H), 2.60 (dd, J = 12.9, 9.6 Hz, 1H), 2.45 (dd, J = 12.9, 8.9 Hz, 1H), 1.67 (s, 1H), 0.72 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ 140.09 (C), 128.12 (CH), 127.87 (CH), 126.30 (CH), 100.35 
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(CH), 78.90 (C), 77.47 (CH2), 51.94 (C), 39.41 (CH), 32.05 (CH2), 11.68 (CH3). (ESI): 243.1 (M+ 
Na), 173.1, 131.1, 105.1. HRMS Calculated for C13H16NaO3: 243.0992, found 243.0986. 
 
Figure S10. nOe signals observed for 9a 
Studies on the stereospecificity of the process. Cycloaddition between 1a and Z-2b . 
 
The cycloaddition of the Z-2b provided the same cycloadduct (Z-3ab) than that obtained from E-
2b. A potential isomerization of the hydrazone (Z-2a) to the more stable E-counterpart during 
the reaction could be ruled out by submitting the hydrazone Z-2b to the reaction conditions, in 
the absence of the allenamide: after 5h, Z-2b had not been converted to the E-counterpart (E-
3ab) and could be recovered or, alternatively, if allenamide 1a was added, the cycloadduct Z-
3ab was obtained in good yield. Moreover, analysis of this reaction by 1H-NMR at different 
conversions did not show the presence of E-2b in the reaction media. 
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